Advertisement

Advertisement

GB:CRTX Stock Latest News

CRISM Therapeutics reshapes board leadership as it advances toward phase 2 trial

Company AnnouncementsCRISM Therapeutics reshapes board leadership as it advances toward phase 2 trial

CRISM Therapeutics Pushes Phase 2 Glioblastoma Trial Start to H1 2026 After First ChemoSeed Batch Produced

PremiumCompany Announcements

CRISM Therapeutics Pushes Phase 2 Glioblastoma Trial Start to H1 2026 After First ChemoSeed Batch Produced

21d ago

CRISM Wins FDA Orphan Drug Status for Glioma ChemoSeed Programme

PremiumCompany Announcements

CRISM Wins FDA Orphan Drug Status for Glioma ChemoSeed Programme

29d ago

CRISM Therapeutics Wins Key Japanese Patent for ChemoSeed Cancer Implant

PremiumCompany Announcements

CRISM Therapeutics Wins Key Japanese Patent for ChemoSeed Cancer Implant

3M ago

CRISM Therapeutics Reveals Updated Major Shareholders After December Fundraising

PremiumCompany Announcements

CRISM Therapeutics Reveals Updated Major Shareholders After December Fundraising

3M ago

CRISM Therapeutics Raises Funds for Glioblastoma Trial

PremiumCompany AnnouncementsCRISM Therapeutics Raises Funds for Glioblastoma Trial

4M ago

CRISM Therapeutics Launches £100,000 Retail Offer to Fund Clinical Trial

Company Announcements

CRISM Therapeutics Launches £100,000 Retail Offer to Fund Clinical Trial

4M ago

CRISM Therapeutics Secures £1 Million for Phase 2 Glioblastoma Trial

Company Announcements

CRISM Therapeutics Secures £1 Million for Phase 2 Glioblastoma Trial

4M ago

CRISM Therapeutics Seeks FDA Orphan Drug Designation for Glioblastoma Treatment

PremiumCompany Announcements

CRISM Therapeutics Seeks FDA Orphan Drug Designation for Glioblastoma Treatment

6M ago

CRISM Therapeutics Advances Prostate Cancer Treatment with ChemoSeed Platform

PremiumCompany Announcements

CRISM Therapeutics Advances Prostate Cancer Treatment with ChemoSeed Platform

6M ago

CRISM Therapeutics Advances ChemoSeed Technology for Cancer Treatment

PremiumCompany Announcements

CRISM Therapeutics Advances ChemoSeed Technology for Cancer Treatment

7M ago

CRISM Therapeutics to Announce Interim Results and Discuss Phase 2 Glioblastoma Trial

PremiumCompany Announcements

CRISM Therapeutics to Announce Interim Results and Discuss Phase 2 Glioblastoma Trial

7M ago

CRISM Therapeutics Secures Approval for Phase 2 Glioblastoma Trial

PremiumCompany AnnouncementsCRISM Therapeutics Secures Approval for Phase 2 Glioblastoma Trial

8M ago

CRISM Therapeutics Secures Shareholder Backing at AGM

Company Announcements

CRISM Therapeutics Secures Shareholder Backing at AGM

8M ago

CRISM Therapeutics Marks Milestones in Cancer Treatment Innovation

Company Announcements

CRISM Therapeutics Marks Milestones in Cancer Treatment Innovation

8M ago

CRISM Therapeutics Begins GMP Production of ChemoSeed for Glioblastoma Trial

PremiumCompany Announcements

CRISM Therapeutics Begins GMP Production of ChemoSeed for Glioblastoma Trial

8M ago

CRISM Therapeutics Announces AGM and New Incentive Plan

PremiumCompany Announcements

CRISM Therapeutics Announces AGM and New Incentive Plan

8M ago

CRISM Therapeutics Announces Change in Major Holdings

PremiumCompany Announcements

CRISM Therapeutics Announces Change in Major Holdings

9M ago

CRISM Therapeutics Raises £874,021 to Advance Cancer Treatment Technology

PremiumCompany Announcements

CRISM Therapeutics Raises £874,021 to Advance Cancer Treatment Technology

10M ago

CRISM Therapeutics Updates Investors on Funding and Future Plans

PremiumCompany AnnouncementsCRISM Therapeutics Updates Investors on Funding and Future Plans

10M ago

CRISM Therapeutics Advances Glioblastoma Treatment with Phase 2 Trial

Company Announcements

CRISM Therapeutics Advances Glioblastoma Treatment with Phase 2 Trial

10M ago

CRISM Therapeutics Launches Retail Offer to Fund ChemoSeed Development

Company Announcements

CRISM Therapeutics Launches Retail Offer to Fund ChemoSeed Development

10M ago

Trending

S&P 500

―

Dow Jones

―

Nasdaq 100

―

More Trending Stocks >